Pure red cell aplasia associated with fenoprofen.

ABSTRACT

A 69-year-old man developed pure red cell aplasia after taking fenoprofen for ten months. The erythroid defect fully reversed after the drug was discontinued and could not be attributed to the patient's previously treated lung carcinoma. This case represents the third example of erythroid aplasia associated with an anti-inflammatory agent and the first instance due to fenoprofen.